A self-evolving multi-agent system called EvoMDT is being reported in relation to structured clinical decision-making in multi-cancer cases. This system is part of a broader trend in precision oncology that includes the use of large language models. The specifics of EvoMDT's application and effectiveness are not detailed in the available information.